Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Alivus Life Sciences Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
543322
INE03Q201024
207.1673323
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
ALIVUS
31.92
13517.83
EPS(TTM)
Face Value(
)
Div & Yield %:
34.56
2
2.04
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
2283.21
2161.22
2123.21
1885.17
1537.31
886.42
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2283.21
2161.22
2123.21
1885.17
1537.31
886.42
Other Income
12.04
28.96
14.70
0.81
11.99
0.44
Stock Adjustments
56.57
84.44
-41.32
70.70
4.64
301.59
Total Income
2351.82
2274.62
2096.59
1956.68
1553.94
1188.45
EXPENDITURE :
Raw Materials
1025.21
1068.56
977.96
948.17
668.66
633.56
Power & Fuel Cost
112.46
115.60
100.92
74.19
76.75
57.81
Employee Cost
258.16
180.18
168.72
149.13
142.28
106.28
Other Manufacturing Expenses
163.64
137.17
124.04
107.32
108.04
77.09
Selling & Administrative Expenses
64.12
65.47
48.64
48.50
42.05
44.20
Miscellaneous Expenses
41.97
36.39
45.56
37.49
32.22
21.35
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1665.54
1603.36
1465.83
1364.80
1069.99
940.29
Operating Profit
686.29
671.25
630.76
591.89
483.96
248.17
Interest
1.55
0.55
27.96
87.55
33.52
0.61
Gross Profit
684.74
670.70
602.80
504.34
450.44
247.56
Depreciation
53.45
42.09
37.88
33.39
29.37
19.26
Profit Before Tax
631.29
628.61
564.92
470.95
421.07
228.30
Tax
152.21
150.61
137.63
112.75
98.54
25.90
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
8.19
11.04
8.57
6.62
9.43
6.81
Reported Net Profit
470.89
466.96
418.72
351.58
313.10
195.59
Extraordinary Items
-0.53
-0.41
-0.55
-0.44
-0.91
-0.54
Adjusted Net Profit
471.42
467.37
419.27
352.02
314.01
196.13
Adjustment below Net Profit
-5.46
-0.29
-19.50
-0.53
0.47
-108.02
P & L Balance brought forward
1102.06
1021.35
750.79
399.73
86.17
-1.41
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
275.69
385.96
128.65
0.00
0.00
0.00
P & L Balance carried down
1291.80
1102.06
1021.35
750.79
399.73
86.17
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
1125.00
2100.00
1050.00
0.00
0.00
0.00
Dividend Per Share(Rs)
22.50
42.00
21.00
0.00
0.00
0.00
Earnings Per Share-Unit Curr
38.43
38.11
34.17
358.76
1597.44
997.92
Earnings Per Share(Adj)-Unit Curr
38.43
38.11
34.17
358.76
1597.44
997.92
Book Value-Unit Curr
190.35
174.51
167.66
768.11
2049.45
449.62
Book Value(Adj)-Unit Curr
190.35
174.51
167.66
768.11
2049.45
449.62